# EDGAR Filing Document

**Accession Number:** 0001553788
**File Stem:** 0000000000-25-006716
**Filing Date:** 2025-6
**Character Count:** 5351
**Document Hash:** c76a9c17d4d3f2e59dc01857fd7f311e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-006716.hdr.sgml**: 20250929

**ACCESSION NUMBER**: 0000000000-25-006716

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250626

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SPLASH BEVERAGE GROUP, INC.
- **CENTRAL INDEX KEY:** 0001553788
- **STANDARD INDUSTRIAL CLASSIFICATION:** BEVERAGES [2080]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 341720075
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 001-40471

**BUSINESS ADDRESS:**
- **STREET 1:** 1314 E LAS OLAS BLVD, SUITE 221
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33301
- **BUSINESS PHONE:** 954.745.5815

**MAIL ADDRESS:**
- **STREET 1:** 1314 E LAS OLAS BLVD, SUITE 221
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33301

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Canfield Medical Supply, Inc.
- **DATE OF NAME CHANGE:** 20120709
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001731122-25-000877

## Text-Extract

```

                                                               June 26, 2025

Robert Nistico
Chief Executive Officer
Splash Beverage Group, Inc.
1314 East Las Olas Blvd, Suite 221
Fort Lauderdale, Florida 33301

       Re: Splash Beverage Group, Inc.
           Preliminary Proxy Statement on Schedule 14A
           Filed on June 13, 2025
           File No. 001-40471
Dear Robert Nistico:

       We have reviewed your filing and have the following comments.

       Please respond to this letter within ten business days by providing the
requested
information or advise us as soon as possible when you will respond. If you do
not believe a
comment applies to your facts and circumstances, please tell us why in your
response.

       After reviewing your response to this letter, we may have additional
comments.

Preliminary Proxy Statement on Schedule 14A
Proposal 1 -- To Approve an Amendment to Our Articles of Incorporation, as
Amended, to
Increase the Number of Authorized Shares of Common St, page 8

1.     We note one of the purposes for increasing the number of authorized
shares is to offer
       additional flexibility to "make stock-based acquisitions". We also note
in your 8-K
       filed on February 3, 2025, you have signed a letter of intent to acquire
Western Son
       Vodka primarily through a stock-for-equity transaction. If the increase
in authorized
       shares covered by this proposal is in furtherance of the acquisition of
Western Son
       Vodka, please note that Note A to Schedule 14A provides that where a
solicitation of
       securityholders is for the purpose of approving the authorization of
additional
       securities which are to be used to acquire another specified company,
and the
       registrants' securityholders will not have a separate opportunity to
vote upon the
       transaction, the solicitation to authorize the securities is also a
solicitation with respect
       to the acquisition. Under those facts, information required by Items 11,
13 and 14
       shall be furnished. Alternatively, please provide us with analysis
supporting why such
       disclosure is not required.
 June 26, 2025
Page 2

General

2.     We note that you have not filed your Annual Report on Form 10-K for your
fiscal
       year ended December 31, 2024, and that you have not filed your Quarterly
Report on
       For 10-Q for the period ended March 31, 2025. Please add a risk factor
to discuss
       these facts, any obligations you have to file these reports, and
associated risks
       resulting from your failure to do so.

3.     We note that you received a notice from NYSE American LLC on April 16,
2025
       notifying you that you were not in compliance with the continued listing
standards
       due to failure to timely file your Annual Report on Form 10-K for the
year ended
       December 31, 2024. Additionally, we note that you received a notice from
NYSE
       American LLC on April 7, 2025 that NYSE would begin delisting procedures
due to
       failure to regain compliance with Sections 1003(a)(i), (ii), and (iii)
of the Company
       Guide, and that you were appealing such decision. Please provide a
detailed
       description for both NYSE notices of the processes undertaken by the
Company to
       regain compliance and their related timelines. Please disclose the risks
of non-
       compliance with either notice, as well as the consequences of any such
suspension or
       delisting.
4.     Please include a form of proxy card marked as "preliminary" in your next
amendment.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.

      Please contact Sarah Sidwell at 202-551-4733 or Asia Timmons-Pierce at
202-551-
3754 with any other questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of
Manufacturing
cc:   Darrin Ocasio

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._